Portfolio company
Omniscope
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
Omniscope develops an immune intelligence platform for individuals, clinicians and researchers to track immune system health, disease drivers and cellular aging over time.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
IMU
IMU Biosciences develops an immune profiling platform using machine learning to provide diagnostic insights for clinicians, researchers and pharmaceutical companies.
Compound Life
This company develops a biomarker profiling and health tracking platform for individuals seeking to monitor their healthspan and biological age.
MetaSight
MetaSight Diagnostics develops multi-omics liquid biopsy tests for the early detection of chronic and acute diseases for healthcare providers and patients.
Immunai
Immunai develops an immune system mapping platform for biopharmaceutical companies to discover and optimise drug targets and clinical trials.
OMNIA-X
This company develops a health intelligence platform that integrates medical, biometric and behavioural data to provide personalised psychophysical health analysis for individuals.
Generation Lab
Generation Lab develops a diagnostic platform measuring biological age and organ health for clinical providers and individuals seeking longevity monitoring.
Q Bio
Q Bio provides a whole-body medical imaging platform and dashboard to healthcare providers for longitudinal health monitoring and preventive care.
Kascaid
This company develops interstitial fluid biosensors for real-time immune monitoring to support biopharma companies and researchers during clinical trials.
